Moreover, Nrf2 plays a key role in tumor resistance to chemoradiotherapy, proliferation, and migration; therefore, it is a markedly promising antitumor strategy to promote ROS production and suppress key signaling pathways, such as proliferation, migration, and DNA repair by inhibiting the Keap1/Nrf2/ARE pathway. This evidence concerns the gene KEAP1 and neoplasm.